[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

The Future of MRD Testing: Why It Matters for Multiple Myeloma Patients and What Comes Next

The Future of MRD Testing: Why It Matters for Multiple Myeloma Patients and What Comes Next image

The Future of MRD Testing: Why It Matters for Multiple Myeloma Patients and What Comes Next

Webinar
event Jan 30, 2025 / 01:00PM - 02:00PM EST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. Neha Korde, from Memorial Sloan Kettering Cancer Center, will join us to discuss Minimal Residual Disease (MRD) testing, it's role in monitoring multiple myeloma, and how it influences treatment decisions. We’ll cover current MRD testing techniques, including exciting advancements in blood-based MRD testing, which offer a less invasive option for patients. We will also discuss Dr. Korde's research which is looking at "Stopping Maintenance Therapy in People with Sustained MRD-Negativity", and how this may shape the future of care.

 

Event Highlights

What MRD Testing Is and Its Importance

expand_more

MRD Methodologies and Their Components

expand_more

Sensitivity of MRD Tests

expand_more

Liquid Chromatography-Mass Spectrometry

expand_more

Peripheral Blood and Bone Marrow

expand_more

Beyond MRD for Treatment Decisions

expand_more

Questions & Answers

expand_more

Schedule & Agenda

The panelist Cynthia Cahoon, RN
1:00 PM
Introductions
Cynthia Cahoon, RN

Cynthia introduces the agenda of the event and featured speaker Dr. Neha Korde

The panelist Neha S. Korde, MD
1:05 PM
Presentation
Neha S. Korde, MD

Dr. Neha Korde talks about MRD testing for myeloma patients

Event panelist Audience
1:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon, RN
Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Neha S. Korde, MD
Neha S. Korde, MD

I am a board-certified hematologist specializing in the treatment of multiple myeloma and other plasma cell neoplasms. I have a particular research interest in early plasma cell disorders, including monoclonal gammopathy of unknown significance (MGUS) and smoldering myeloma (SMM), and understanding disease biology that may promote transition to frank symptomatic multiple myeloma in some individuals. My colleagues at Memorial Sloan Kettering Cancer Center and I offer a variety of treatment options (on and off clinical trial) for patients with multiple myeloma and high-risk SMM, including access to the latest novel drugs and immune-therapeutic approaches. Recent therapeutic advances have led to improved outcomes for people with multiple myeloma, and I am working on developing methods of monitoring minimal residual disease. By understanding mechanisms of tumor resistance with current available drugs and monitoring techniques, we aim to drive myeloma research forward and develop new strategies of tumor control or eradication.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Lab Values and Testing group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.